Skip to main content
. 2020 Feb;41(2):255–261. doi: 10.3174/ajnr.A6384

Table 3:

Perfusion parameters of benign and malignant tumors on the quantitative evaluation

Benign Tumors Mean (± SD) Malignant Tumors Mean (± SD) Pa Sensitivity (%) Specificity (%) Accuracy (%)
All lesions (n = 86)b
 mpASL rrCBF 1.19 (0.59) 2.84 (1.44) <.001 85.4 84.4 84.9
 DSC rrCBF 1.19 (0.69) 2.93 (1.57) <.001 82.9 80.0 81.45
 DSC rrCBV 1.20 (0.62) 3.07 (1.43) <.001 68.3 97.8 83.05
Group 1 (n = 38)c
 mpASL rrCBF 1.24 (0.47) 3.06 (1.45) <.001 94.4 80.0 87.2
 DSC rrCBF 1.33 (0.83) 3.13 (1.80) <.001 88.9 75.0 81.95
 DSC rrCBV 1.32 (0.67) 3.22 (1.43) <.001 66.7 100 83.35
Group 2 (n = 48)d
 mpASL rrCBF 1.16 (0.68) 2.67 (1.45) <.001 78.3 88.0 83.15
 DSC rrCBF 1.08 (0.54) 2.77 (1.39) <.001 78.3 84.0 81.15
 DSC rrCBV 1.10 (0.58) 2.96 (1.45) <.001 69.6 96.0 82.8
a

Mann-Whitney U test.

b

Benign (n = 45), malignant (n = 41).

c

Benign (n = 20), malignant (n = 18).

d

Benign (n = 25), malignant (n = 23).